← Back to Search

Liposomal vitamin C, 5 grams for Pharmacokinetics

N/A
Recruiting
Led By Gitte Jensen, PhD
Research Sponsored by Natural Immune Systems Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult people of either gender;
BMI between 18.0 and 34.9 (inclusive);
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours
Awards & highlights

Study Summary

This trial is testing how well different doses of liposomal vitamin C are absorbed by the body and what effects the vitamin C has on the body.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Both men and women over 18 years old.
Select...
Your body mass index (BMI) falls between 18.0 and 34.9.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation of vitamin C levels
Secondary outcome measures
Evaluation of antioxidant status
Other outcome measures
Evaluation of downstream effects reflecting antioxidant protection

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Liposomal vitamin C, 5 gramsActive Control1 Intervention
Participants will consume 5 grams on study day
Group II: Liposomal vitamin C, 1 gramActive Control1 Intervention
Participants will consume 1 gram on study day
Group III: Liposomal vitamin C, 2 gramsActive Control1 Intervention
Participants will consume 2 grams on study day
Group IV: PlaceboPlacebo Group1 Intervention
Participants will consume placebo on study day

Find a Location

Who is running the clinical trial?

Natural Immune Systems IncLead Sponsor
18 Previous Clinical Trials
463 Total Patients Enrolled
2 Trials studying Pharmacokinetics
48 Patients Enrolled for Pharmacokinetics
Gitte Jensen, PhDPrincipal Investigator - NIS Labs
Natural Immune Systems Inc
4 Previous Clinical Trials
102 Total Patients Enrolled
1 Trials studying Pharmacokinetics
24 Patients Enrolled for Pharmacokinetics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age limit for this trial restricted to individuals beneath thirty years old?

"This clinical trial is only accepting participants between the ages of 18 and 70, but there are 31 other studies available for people outside this range. Specifically, 3 trials cater to those under 18 years old while 28 serve patients 65 or older."

Answered by AI

Are there still opportunities for individuals to participate in this research?

"According to the clinicaltrials.gov listing, this medical experiment is in the process of recruiting participants. It was initially posted on July 1st 2020 and most recently updated on September 26th 2022."

Answered by AI

Who meets the qualifications to partake in this investigation?

"24 volunteers of any gender between the ages 18-70 who meet specific criteria are being admitted to this pharmacokinetics trial. These requirements include an acceptable Body Mass Index (18.0 - 34.9), abstaining from coffee, tea and carbonated beverages for one hour prior to a health centre visit, avoiding alcohol 12 hours before clinic attendance, and refraining from exercise, nicotine use or taking nutritional supplements on the morning of their assessment session."

Answered by AI

What is the total enrollment of individuals for this research project?

"Affirmative. The information hosted on clinicaltrials.gov demonstrates that recruitment for this medical trial is ongoing, with the original posting made on July 1st 2020 and a recent edit from September 26th 2022. A total of 24 participants need to be recruited from one site."

Answered by AI
~5 spots leftby Mar 2025